Try our Advanced Search for more refined results

Pfizer Wins Preliminary Injunction Vs. Teva, Ranbaxy In Accupril Suit

By Marius Meland ( March 29, 2005, 12:00 AM EST) -- Pfizer, Inc. has won a preliminary injunction halting sales of a generic version of the hypertension drug Accupril, marketed by Israeli generics maker Teva Pharmaceuticals and Indian drug maker Ranbaxy Pharmaceuticals. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Judge Analytics

powered by Lex Machina®

Law360 Reveals Titans Of The Plaintiffs Bar

This past year, a handful of attorneys secured billions of dollars in settlements and judgments for both classes and individual plaintiffs against massive companies and organizations like Facebook, Dell, the National Association of Realtors, Johnson & Johnson, UFC and Credit Suisse, earning them recognition as Law360's Titans of the Plaintiffs Bar for 2025.